WASHINGTON (Reuters) - U.S. regulators gave the nod to GlaxoSmithKline Plc's Votrient for a type of sarcoma on Thursday, following a positive advisory panel vote last month.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/WeHo6ZSmQAo/us-glaxosmithkline-idUSBRE83O0O220120426
save money travel make money best news online money internet business
No comments:
Post a Comment